$58.07
-0.82 (-1.39%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+4.50%
1Y
+94.21%
YTD
+24.99%
Open$59.91
Previous Close$58.89
Day High$60.08
Day Low$56.74
52W High$65.00
52W Low$29.08
Volume—
Avg Volume999.9K
Market Cap8.64B
P/E Ratio—
EPS$-6.89
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$49.46
Above
SMA 200
$39.88
Above
RSI (14)
62.6
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
17 analysts
Price Target
+15.5% upside
Current
$58.07
$58.07
Target
$67.08
$67.08
$56.09
$67.08 avg
$108.72
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 3.07B | 3.02B | 2.41B |
| Net Income | 147.42M | 150.65M | 124.53M |
| Profit Margin | 4.8% | 5.0% | 5.2% |
| EBITDA | 264.93M | 279.22M | 238.21M |
| Free Cash Flow | 132.34M | 114.72M | 94.55M |
| Rev Growth | +1.9% | +8.9% | +10.2% |
| Debt/Equity | 1.24 | 1.35 | 1.48 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |